COMPLETED

Appropriateness of Frozen Plasma Use in Canada

NCT01187030•Ottawa Hospital Research Institute

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Blood Component Transfusion

Key Dates

Start Date

May 1, 2008

Primary Completion Date

March 1, 2011

Completion Date

March 1, 2011

Last Updated

May 23, 2012

Related Studies

COMPLETEDPhase 4

Immunomodulation Following Transfusion

NCT00810810

Blood Component Transfusion

View study

COMPLETED

Plasma Utilization Following Cardiac Surgery

NCT01187394

Blood Component TransfusionCardiac Surgical Procedures

View study

Sponsors

Lead Sponsor

Ottawa Hospital Research Institute

Collaborators

Canadian Blood Services
Canadian Institutes of Health Research (CIHR)

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 23, 2012Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions